Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Evotec and Novo Nordisk in technology development partnership
Evotec to receive funding and potential milestone payments as Novo Nordisk explores stem cell-based therapies in diabetes and…
Merck’s colorectal cancer therapy fails late-stage trial
Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss
Pfizer withdraws sickle cell disease treatment on risk of complication, death
Pfizer ends all studies and access to Oxbryta as risks outweigh benefits, based on clinical data
Dr Reddy’s fined by Mexican health regulator for compliance violation
COFEPRIS imposes penalty on Indian pharmaceutical company for deviation in import filing guidelines
India’s reputation as the “Pharmacy to the World” is potentially under threat, substandard imports…
By FY 2023, Chinese imports accounted for 64 per cent of India’s IPA supply. Vikas Biyani – FDA Regulatory Consultant states that…
Biocon Biologics announces new dermatology data to be presented at EADV Congress 2024
Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports…
FOPE and PharmaState Academy’s PULSE initiative delivers insights on water systems and…
The session attracted over 180 attendees, continuing the PULSE series' role as a key learning platform for industry professionals…
FABA signs MoU with Thu Dau Mot University, and collaborates with Binh Duong Business Association,…
The collaborations aim to bolster biotechnological education and strengthen business ties between Vietnam and India, in the…
Catalytic Droplets leading to faster chemical reactions can bring quicker access to innovative…
Scientists at INST, Mohali, an autonomous institute of the Department of Science and Technology explored a way to confine…
AstraZeneca India receives CDSCO approval for Durvalumab for specified additional indication
Durvalumab in combination with chemotherapy as neoadjuvant treatment, followed by Durvalumab as monotherapy after surgery, is…